1-9 of 9
Helen Kaul
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial

Free
Justin Ferdinandus, Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Yon-Dschun Ko, Felicitas Hitz, Michaela Schwarz, Corinna Trenker, Andrea Kerkhoff, Peter Staib, Kai Wille, Irmgard Dresel, Dennis Hahn, Bernd Hertenstein, Peter Moosmann, Ulrich Mey, Stefan Balabanov, Tasman Armytage, Fernando Roncolato, Johannes Christian Hellmuth, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Hishan Tharmaseelan, Dennis A Eichenauer, Bastian von Tresckow, Peter Borchmann, Paul J. Bröckelmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 568.
https://doi.org/10.1182/blood-2024-207946
Published: 2024
Journal Articles

Metabolic Tumor Volume after Two Cycles of Chemotherapy in Patients Treated for Advanced-Stage Hodgkin Lymphoma: Analysis of the German Hodgkin Study Group Phase III HD18 and HD21 Trials

Free
Justin Ferdinandus, Helen Kaul, Gundolf Schneider, Michael Fuchs, Hans Theodor Eich, Christian Baues, Johannes Rosenbrock, Katrin S Roth, Alexander Drzezga, Lutz Van Heek, Markus Dietlein, Peter Borchmann, Carsten Kobe
Journal: Blood
Blood (2024) 144 (Supplement 1): 566.
https://doi.org/10.1182/blood-2024-210791
Published: 2024
Journal Articles

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Free
Paul J. Bröckelmann, Sophie Teesink, Lydia Visser, Conrad-Amadeus Voltin, Helen Kaul, Hans Schlösser, Bart-Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter Plattel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3044.
https://doi.org/10.1182/blood-2024-201547
Published: 2024
Journal Articles

Lymphovista HL - a Validated Assay for Genotyping and MRD Assessment in Hodgkin Lymphoma

Free
Julia Mattlener, Justin Ferdinandus, Jessica Schneider, Julia K. Schleifenbaum, Max Freihammer, Olivia Käsgen, Hodgkin Lymphoma MRD Consortium, Helen Kaul, Gundolf Schneider, Peter Borchmann, Jan-Michel Heger, Sven Borchmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 4355.
https://doi.org/10.1182/blood-2024-205034
Published: 2024
Journal Articles

Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma: Final Results of the GHSG-NLG Phase II Bvb Trial

Free
Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob Haaber Christensen, Ulf Schnetzke, Michael Fuchs, Dennis A Eichenauer, Bastian von Tresckow, Helen Kaul, Peter Borchmann, Alexander Fossa
Journal: Blood
Blood (2024) 144 (Supplement 1): 3054.
https://doi.org/10.1182/blood-2024-202120
Published: 2024
Journal Articles

Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies

Free
Clinical Trials & Observations
Dennis A. Eichenauer, Ina Bühnen, Christian Baues, Carsten Kobe, Helen Kaul, Richard Greil, Alden Moccia, Joseé M. Zijlstra, Bernd Hertenstein, Max S. Topp, Marianne Just, Bastian von Tresckow, Hans-Theodor Eich, Michael Fuchs, Markus Dietlein, Sylvia Hartmann, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2023) 142 (6): 553–560.
https://doi.org/10.1182/blood.2023019939
Published: 2023
Journal Articles

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Free
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann-Grill, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Journal: Blood
Blood (2022) 140 (Supplement 1): 1753–1755.
https://doi.org/10.1182/blood-2022-168846
Published: 2022
Journal Articles

Treatment of Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Subgroup Analysis of the Randomized German Hodgkin Study Group HD16 Study

Free
Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Helen Kaul, Carsten Kobe, Sylvia Hartmann, Christian Baues, Bastian von Tresckow, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2021) 138 (Supplement 1): 2439.
https://doi.org/10.1182/blood-2021-145427
Published: 2021
Journal Articles

PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial By the German Hodgkin Study Group

Free
Michael Fuchs, Anne Sophie Jacob, Helen Kaul, Carsten Kobe, Thomas Pabst, Richard Greil, Dennis A. Eichenauer, Max Topp, Marianne Just, Bernd Hertenstein, Valdete Schaub, Martin Vogelhuber, Josée M Zijlstra, Annette Plütschow, Christian Baues, Andreas Rosenwald, Markus Dietlein, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2021) 138 (Supplement 1): 2438.
https://doi.org/10.1182/blood-2021-152260
Published: 2021